Blog Page

Nivalis Therapeutics and Seattle's Alpine Immune Sciences to merge

BOULDER -- Nivalis Therapeutics, Inc. (NASDAQ: NVLS) and Seattle-based Alpine Immune Sciences, Inc., a privately-held biotechnology company developing novel therapies using its next-generation... Read More

Thursday April 20, 2017 Tags: Boulder, Nivalis Therapeutics, Alpine Immune Sciences, Howard Furst, Mitchell H. Gold

CBSA: 2015 was groundbreaking year for life sciences industry

DENVER -- Colorados life sciences sector had a robust and groundbreaking 2015, according to the Colorado BioScience Association (CBSA), the states advocate for the industry. CBSA reported... Read More

Wednesday December 16, 2015 Tags: Denver, CBSA, April Giles, Medtronic, Covidien, Nivalis Therapeutics, Precision Biopsy, miRagen Therapeutics, Spectranetics, Surefire Medical, Cerapedics, dbMEDx, Clovis Oncology

Five honored at 12th Annual Colorado BioScience Association Awards Dinner

DENVER -- Colorados thriving life science sector celebrated the states most inventive bioscience companies, researchers and volunteers on Thursday at the 12 th annual Colorado BioScience... Read More

Friday November 13, 2015 Tags: Denver, CBSA, CBSA 12th Annual Awa, April Giles, Medtronic, SomaLogic, Nivalis Therapeutics, Mandi Ruud, Mark Lupa, MedKeeper, KBI Biopharma, dbMEDx, Mighty Oak Medical, Boettcher Foundation

CBSA Awards Dinner on Nov. 12 will honor state’s life sciences leaders

DENVER -- Leaders from Colorados life sciences sector will gather Nov. 12 to celebrate the states most inventive bioscience companies, researchers and volunteers at the annual Colorado... Read More

Friday October 30, 2015 Tags: Denver, CBSA, CBSA 12th Annual Awa, April Giles, Amy Van Dyken-Rouen, MedKeeper, KBI Biopharma, SomaLogic, dbMEDx, Mighty Oak Medical, Nivalis Therapeutics